S
GBIO

SignatureFD’s Generation Bio GBIO Stock Holding History

SignatureFD’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-44
Closed -$2K – 3327
2022
Q3 		$2K Buy
44
+8
+22% +$500 ﹤0.01% 2771
2022
Q2 		$2K Buy
36
+27
+300% +$1.76K ﹤0.01% 2741
2022
Q1 		$1K Sell
9
-134
-94% -$7.76K ﹤0.01% 2990
2021
Q4 		$10K Buy
143
+140
+4,667% +$24.4K ﹤0.01% 2116
2021
Q3 		$1K Hold
3
– – ﹤0.01% 2824
2021
Q2 		$1K Buy
+3
New +$897 ﹤0.01% 2726

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

SignatureFD's GBIO Position: Q4 2022 in Review

SignatureFD sold out of Generation Bio (GBIO) in Q4 2022, closing a stake of 44 shares — an estimated $2K sold.

SignatureFD first reported a position in GBIO in Q2 2021 and held it in 6 quarters. The position peaked at $10K in Q4 2021. 95 funds tracked by Wall St. Rank hold GBIO as of Q4 2022.

  • SignatureFD reported no remaining Generation Bio position as of Q4 2022 after selling out during the quarter.
  • SignatureFD sold 44 Generation Bio shares in Q4 2022, an estimated $2K.
  • SignatureFD first reported a position in Generation Bio in Q2 2021 and held it in 6 quarters.
  • SignatureFD's Generation Bio position peaked at $10K in Q4 2021.
  • 95 funds tracked by Wall St. Rank held Generation Bio as of Q4 2022.

Based on SignatureFD's 13F filing for Q4 2022, filed 30 Jan 2023.